Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Fluorouracil 9 Oxaliplatin 8 Nivolumab 7 Leucovorin 7 Capecitabine 7 pembrolizumab 3 Trastuzumab 3 Specimen Handling 3 Paclitaxel 3 Cisplatin 3 zimberelimab 2 zanidatamab 2 dehydroftorafur 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Docetaxel 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 quemliclustat 1 obeticholic acid 1 durvalumab 1 Taxes 1 Ramucirumab 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡